LIVE FREE OR DIE LEGAL
This website is not an official source of law. This website does not provide legal advice. For official legal materials, verify against the relevant court, legislature, agency, or other official source. Legal information may be incomplete, outdated, or incorrectly processed. Consult a qualified attorney for advice about a specific legal matter.

This page is an unofficial LFoD record and is not legal advice. Verify the document against the official source before relying on it.

HB223: relative to prescription refills.

Bill status: Signed by Governor

Citation
2023 HB223
Official source

Bill details

Version history, amendments, and roll-call votes were not present in the imported local bill data.

House status
Passed/Adopted
Senate status
Passed/Adopted
Committee
Senate Health and Human Services
Hearing
03/22/2023 at 09:30 AM
Selected version
Current official bill text

Sponsors

Topics

Health and Human Services

Official links

CHAPTER 22

HB 223 - FINAL VERSION

2023 SESSION

23-0392

05/08

HOUSE BILL 223

AN ACT relative to prescription refills.

SPONSORS: Rep. D. McGuire, Merr. 14; Rep. Merchant, Sull. 6

COMMITTEE: Health, Human Services and Elderly Affairs

ANALYSIS

This bill creates an exception to the 34-day limit on prescription refills of schedule III topical androgens if the prescription specifies it is being used for the treatment of chronic low testosterone replacement therapy.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

23-0392

05/08

STATE OF NEW HAMPSHIRE

In the Year of Our Lord Two Thousand Twenty Three

AN ACT relative to prescription refills.

Be it Enacted by the Senate and House of Representatives in General Court convened:

22:1 Controlled Drugs; Sale by Pharmacists. Amend RSA 318-B:9, IV to read as follows:

IV. No prescription shall be filled for more than a 34-day supply upon any single filling for controlled drugs of schedules II or III; provided, however, that for controlled drugs, in schedules II or III, that are commercially packaged for dispensing directly to the patient, such as metered sprays and inhalers, liquids packaged in bottles with calibrated droppers, and certain topical preparations packaged with metered dispensing pumps may be filled for greater than a 34-day supply, but not more than 60 days, utilizing the smallest available product size, in order to maintain the dosing integrity of the commercially packaged containers; and, provided that:

(a) With regard to amphetamines and methylphenidate hydrochloride, a prescription may be filled for up to a 90-day supply if either such prescription specifies it is being used for the treatment of attention deficit disorder, attention deficit disorder with hyperactivity, or narcolepsy; and

(b) With regard to a topically applied androgen, a prescription may be filled for up to a 90-day supply if the prescription specifies it is being used for the treatment of chronic low testosterone replacement therapy.

22:2 Effective Date. This act shall take effect January 1, 2024.

Approved: May 04, 2023

Effective Date: January 01, 2024